| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +6.60% | +1.11% | +5.49% | +5.49% | — |
| 14d | 1 | +100.00% | -5.95% | +0.94% | -6.89% | -6.89% | — |
| 30d | 1 | +100.00% | -26.41% | -1.79% | -24.63% | -24.63% | — |
| 60d | 1 | +100.00% | -28.16% | +1.64% | -29.79% | -29.79% | — |
| 90d | 1 | +100.00% | -66.98% | +4.88% | -71.86% | -71.86% | — |
| 180d | 1 | +100.00% | -79.39% | -2.26% | -77.13% | -77.13% | — |
| 1y | 1 | +100.00% | -94.85% | -6.49% | -88.36% | -88.36% | — |
| 2y | 1 | +100.00% | -97.94% | +2.11% | -100.05% | -100.05% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 7,502 | — | — | 33,603 | Sep 2, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | SALE General Counsel & Secretary | 28,916 | $3.07 | $88.8K | 71,924 | Sep 2, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | SALE General Counsel & Secretary | 20,666 | $3.07 | $63.4K | 28,934 | Sep 2, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 10,496 | — | — | 26,101 | Sep 2, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE General Counsel & Secretary | 18,420 | $3.07 | $56.5K | 18,420 | Sep 2, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE General Counsel & Secretary | 13,164 | $3.07 | $40.4K | 31,584 | Sep 2, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | SALE General Counsel & Secretary | 33,715 | $13.11 | $442.0K | 0 | Aug 23, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE General Counsel & Secretary | 27,395 | $3.07 | $84.1K | 33,715 | Aug 19, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 15,605 | — | — | 15,605 | Aug 19, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | SALE General Counsel & Secretary | 43,000 | $3.07 | $132.0K | 100,840 | Aug 19, 2021 | Nov 2, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 143,840 | — | — | 143,840 | May 24, 2021 | Jun 10, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,320 | — | — | 6,320 | May 24, 2021 | Jun 10, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 148,800 | — | — | 148,800 | May 24, 2021 | Jun 10, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 49,600 | — | — | 49,600 | May 24, 2021 | Jun 10, 2021 ↗ | View → |